The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bir Dawn Carter since 2020.
This trader's CIK number is 1688712.
At the time of last reporting, Bir Dawn Carter was the Chief Commercial Officer of Reata Pharmaceuticals Inc. (stock ticker symbol RETA).
Also see all insider trading activities at Reata Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RETA | 0 | $0 | 149,790 | $16,235,314 | 0 | $0 |
| 2020 | RETA | 0 | $0 | 60,000 | $9,750,300 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-28 | RETA | Sale | 40,000 | 164.54 | 6,581,440 |
| 2023-05-16 | RETA | Sale | 417 | 80.95 | 33,758 |
| 2023-05-15 | RETA | Sale | 894 | 85.09 | 76,070 |
| 2023-03-13 | RETA | Sale | 9,317 | 86.77 | 808,436 |
| 2023-03-07 | RETA | Sale | 42,042 | 85.88 | 3,610,693 |
| 2023-03-06 | RETA | Sale | 54,954 | 89.78 | 4,933,770 |
| 2023-03-03 | RETA | Sale | 2,166 | 88.25 | 191,147 |
| 2020-11-09 | RETA | Sale | 60,000 | 162.50 | 9,750,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bir Dawn Carter (Chief Commercial Officer of Reata Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.